SYRS - Syros Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SYRS is currently covered by 5 analysts with an average price target of $32.64. This is a potential upside of $32.42 (14736.36%) from yesterday's end of day stock price of $0.22.

Syros Pharmaceuticals's activity chart (see below) currently has 36 price targets and 54 ratings on display. The stock rating distribution of SYRS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.15% with an average time for these price targets to be met of 267.13 days.

Highest price target for SYRS is $6, Lowest price target is $4, average price target is $32.64.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 01-Nov-2024. First documented stock forecast 18-Jul-2016.

Currently out of the existing stock ratings of SYRS, 20 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$3.39 (129.89%)

$6

2 months 17 days ago
(01-Nov-2024)

2/12 (16.67%)

$3.73 (164.32%)

30

Buy

$5

$2.39 (91.57%)

$7

5 months 5 days ago
(13-Aug-2024)

2/11 (18.18%)

$3.08 (160.42%)

82

Buy

$4

$1.39 (53.26%)

$15

5 months 5 days ago
(13-Aug-2024)

1/5 (20%)

$2.08 (108.33%)

1063

Buy

$13

$5.4 (71.05%)

$15

1 years 10 months 14 days ago
(03-Mar-2023)

1/4 (25%)

$9.07 (230.79%)

155

Buy

$19

$14.86 (358.94%)

$23

2 years 7 months 10 days ago
(08-Jun-2022)

1/3 (33.33%)

$2.24 (59.78%)

17

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SYRS (Syros Pharmaceuticals) average time for price targets to be met?

On average it took 267.13 days on average for the stock forecasts to be realized with a an average price target met ratio 39.15

Which analyst has the current highest performing score on SYRS (Syros Pharmaceuticals) with a proven track record?

ZEGBEH JALLAH

Which analyst has the current lower performing score on SYRS (Syros Pharmaceuticals) with a proven track record?

MATT CROSS

Which analyst has the most public recommendations on SYRS (Syros Pharmaceuticals)?

Zegbeh Jallah works at CAPITAL ONE and has 3 price targets and 5 ratings on SYRS

Which analyst is the currently most bullish on SYRS (Syros Pharmaceuticals)?

Leah Rush Cann with highest potential upside - $14.86

Which analyst is the currently most reserved on SYRS (Syros Pharmaceuticals)?

Zegbeh Jallah with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?